Drug Interaction Study of MGL-3196 With Atorvastatin
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether MGL-3196 alters the pharmacokinetics of
atorvastatin in healthy male subjects and female subjects not of child-bearing potential.